Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001415889-12-001890

Options or other derivatives

  • Director acquired 313,275 shares (grant or award)
  • Director returned 514,800 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Dunkerley Hugh D P · Director

Table II: Derivative

7 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2012-12-21 Returned to the company : show line 1 in the form Employee Stock Options (right to buy) −30,000 $1.50 2017-12-21 30,000 664,800 D
2012-12-21 Returned to the company : show line 2 in the form Employee Stock Options (right to buy) −80,000 $1.50 2018-04-21 80,000 584,800 D
2012-12-21 Returned to the company : show line 3 in the form Employee Stock Options (right to buy) −127,400 $1.55 2020-05-20 127,400 457,400 D
2012-12-21 Returned to the company : show line 4 in the form Employee Stock Options (right to buy) −127,400 $1.55 2020-05-20 127,400 330,000 D
2012-12-21 Returned to the company : show line 5 in the form Employee Stock Options (right to buy) −75,000 $1.55 2020-05-20 75,000 255,000 D
2012-12-21 Returned to the company : show line 6 in the form Employee Stock Options (right to buy) −75,000 $1.54 2021-05-10 75,000 180,000 D
2012-12-21 Grant or award : show line 7 in the form Employee Stock Options (right to buy) +313,275 $0.95 2022-09-15 313,275 493,275 D
Loading xslF345X03/form4-12212012_031221.xml…